These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 9646479)
21. Postantibiotic and physiological effects of tilmicosin, tylosin, and apramycin at subminimal and suprainhibitory concentrations on some swine and bovine respiratory tract pathogens. Diarra MS; Malouin F; Jacques M Int J Antimicrob Agents; 1999 Aug; 12(3):229-37. PubMed ID: 10461841 [TBL] [Abstract][Full Text] [Related]
22. In vitro susceptibility of four antimicrobials against Riemerella anatipestifer isolates: a comparison of minimum inhibitory concentrations and mutant prevention concentrations for ceftiofur, cefquinome, florfenicol, and tilmicosin. Li Y; Zhang Y; Ding H; Mei X; Liu W; Zeng J; Zeng Z BMC Vet Res; 2016 Nov; 12(1):250. PubMed ID: 27829415 [TBL] [Abstract][Full Text] [Related]
23. Antimicrobial susceptibility of Moraxella bovis determined by agar disk diffusion and broth microdilution. Webber JJ; Fales WH; Selby LA Antimicrob Agents Chemother; 1982 Apr; 21(4):554-7. PubMed ID: 7081977 [TBL] [Abstract][Full Text] [Related]
24. Susceptibility of Arcanobacterium pyogenes from different sources to tetracycline, macrolide and lincosamide antimicrobial agents. Trinh HT; Billington SJ; Field AC; Songer JG; Jost BH Vet Microbiol; 2002 Apr; 85(4):353-9. PubMed ID: 11856585 [TBL] [Abstract][Full Text] [Related]
25. Antibiotic susceptibility profiles of Mycoplasma bovis strains isolated from cattle in Hungary, Central Europe. Sulyok KM; Kreizinger Z; Fekete L; Hrivnák V; Magyar T; Jánosi S; Schweitzer N; Turcsányi I; Makrai L; Erdélyi K; Gyuranecz M BMC Vet Res; 2014 Oct; 10():256. PubMed ID: 25344297 [TBL] [Abstract][Full Text] [Related]
26. Tylosin susceptibility of Staphylococci from bovine mastitis. Entorf M; Feßler AT; Kadlec K; Kaspar H; Mankertz J; Peters T; Schwarz S Vet Microbiol; 2014 Jul; 171(3-4):368-73. PubMed ID: 24461550 [TBL] [Abstract][Full Text] [Related]
27. Antimicrobial susceptibilities of Mycoplasma isolated from bovine mastitis in Japan. Kawai K; Higuchi H; Iwano H; Iwakuma A; Onda K; Sato R; Hayashi T; Nagahata H; Oshida T Anim Sci J; 2014 Jan; 85(1):96-9. PubMed ID: 24261609 [TBL] [Abstract][Full Text] [Related]
28. In vitro development of resistance to enrofloxacin, erythromycin, tylosin, tiamulin and oxytetracycline in Mycoplasma gallisepticum, Mycoplasma iowae and Mycoplasma synoviae. Gautier-Bouchardon AV; Reinhardt AK; Kobisch M; Kempf I Vet Microbiol; 2002 Aug; 88(1):47-58. PubMed ID: 12119137 [TBL] [Abstract][Full Text] [Related]
29. Reproduction of bovine keratoconjunctivitis with a purified haemolytic and cytotoxic fraction of Moraxella bovis. Beard MK; Moore LJ Vet Microbiol; 1994 Sep; 42(1):15-33. PubMed ID: 7839582 [TBL] [Abstract][Full Text] [Related]
30. An investigation of colonization of the conjunctival sac of sheep by bacteria and mycoplasmas. Dagnall GJ Epidemiol Infect; 1994 Jun; 112(3):561-7. PubMed ID: 8005222 [TBL] [Abstract][Full Text] [Related]
31. New antimicrobial susceptibility data from monitoring of Mycoplasma bovis isolated in Europe. Klein U; de Jong A; Youala M; El Garch F; Stevenin C; Moyaert H; Rose M; Catania S; Gyuranecz M; Pridmore A; Ayling RD Vet Microbiol; 2019 Nov; 238():108432. PubMed ID: 31648729 [TBL] [Abstract][Full Text] [Related]
32. Antimicrobial susceptibility of Mycoplasma bovis isolates from veal calves and dairy cattle in the Netherlands. Heuvelink A; Reugebrink C; Mars J Vet Microbiol; 2016 Jun; 189():1-7. PubMed ID: 27259820 [TBL] [Abstract][Full Text] [Related]
33. Antimicrobial susceptibility of Arcanobacterium pyogenes isolated from cattle and pigs. Yoshimura H; Kojima A; Ishimaru M J Vet Med B Infect Dis Vet Public Health; 2000 Mar; 47(2):139-43. PubMed ID: 10763384 [TBL] [Abstract][Full Text] [Related]
34. The effect of streptomycin, oxytetracycline, tilmicosin and phenylbutazone on spermatogenesis in bulls. Barth AD; Wood MR Can Vet J; 1998 Feb; 39(2):103-6. PubMed ID: 10051958 [TBL] [Abstract][Full Text] [Related]
35. The antimicrobial susceptibility of Moraxella catarrhalis isolated in England and Scotland in 1991. Fung CP; Powell M; Seymour A; Yuan M; Williams JD J Antimicrob Chemother; 1992 Jul; 30(1):47-55. PubMed ID: 1429336 [TBL] [Abstract][Full Text] [Related]
36. Effect of parenteral administration of erythromycin, tilmicosin, and tylosin on abomasal emptying rate in suckling calves. Nouri M; Constable PD Am J Vet Res; 2007 Dec; 68(12):1392-8. PubMed ID: 18052746 [TBL] [Abstract][Full Text] [Related]
37. Infectious bovine keratoconjunctivitis antimicrobial therapy. McConnel CS; Shum L; House JK Aust Vet J; 2007; 85(1-2):65-9. PubMed ID: 17300463 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of biofilm-forming capacity of Moraxella bovis, the primary causative agent of infectious bovine keratoconjunctivitis. Prieto C; Serra DO; Martina P; Jacobs M; Bosch A; Yantorno OM Vet Microbiol; 2013 Oct; 166(3-4):504-15. PubMed ID: 23907059 [TBL] [Abstract][Full Text] [Related]
39. Comparative minimum inhibitory and mutant prevention drug concentrations of enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin against bovine clinical isolates of Mannheimia haemolytica. Blondeau JM; Borsos S; Blondeau LD; Blondeau BJ; Hesje CE Vet Microbiol; 2012 Nov; 160(1-2):85-90. PubMed ID: 22677482 [TBL] [Abstract][Full Text] [Related]
40. Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella spp. associated with bovine respiratory disease. Shryock TR; White DW; Staples JM; Werner CS J Vet Diagn Invest; 1996 Jul; 8(3):337-44. PubMed ID: 8844577 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]